106 related articles for article (PubMed ID: 29473111)
21. Correction to: Answering biological questions by analysis of the strawberry metabolome.
Haugeneder A; Trinkl J; Härtl K; Hoffmann T; Allwood JW; Schwab W
Metabolomics; 2019 Mar; 15(3):40. PubMed ID: 30852678
[TBL] [Abstract][Full Text] [Related]
22. Correction to: GP2015: An Etanercept Biosimilar.
Deeks ED
BioDrugs; 2018 Oct; 32(5):525. PubMed ID: 30069733
[TBL] [Abstract][Full Text] [Related]
23. Correction to: Industrial antifoam agents impair ethanol fermentation and induce stress responses in yeast cells.
Nielsen JC; Lino FSO; Rasmussen TG; Thykær J; Workman CT; Basso TO
Appl Microbiol Biotechnol; 2018 Jan; 102(1):513. PubMed ID: 29177934
[TBL] [Abstract][Full Text] [Related]
24. Correction to: Migalastat: A Review in Fabry Disease.
McCafferty EH; Scott LJ
Drugs; 2019 Aug; 79(12):1363. PubMed ID: 31292908
[TBL] [Abstract][Full Text] [Related]
25. Correction to: Nonacog Beta Pegol: A Review in Haemophilia B.
Syed YY
Drugs; 2018 Jul; 78(11):1169. PubMed ID: 30003467
[TBL] [Abstract][Full Text] [Related]
26. Correction to: Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Review in HIV-1 Infection.
Deeks ED
Drugs; 2019 Apr; 79(6):687. PubMed ID: 30903610
[TBL] [Abstract][Full Text] [Related]
27. Correction to: OnabotulinumtoxinA: A Review in the Prevention of Chronic Migraine.
Frampton JE; Silberstein S
Drugs; 2018 Apr; 78(6):715. PubMed ID: 29679281
[TBL] [Abstract][Full Text] [Related]
28. Correction to: Revefenacin: First Global Approval.
Heo YA
Drugs; 2019 Apr; 79(6):689. PubMed ID: 30927162
[TBL] [Abstract][Full Text] [Related]
29. Author Correction: Pathogenic bone marrow B cells.
Bernard NJ
Nat Rev Rheumatol; 2019 Feb; 15(2):123. PubMed ID: 30643231
[TBL] [Abstract][Full Text] [Related]
30. Biological responses to cationically charged phosphorylcholine-based materials in vitro.
Rose SF; Lewis AL; Hanlon GW; Lloyd AW
Biomaterials; 2004 Sep; 25(21):5125-35. PubMed ID: 15109836
[TBL] [Abstract][Full Text] [Related]
31. Correction to: Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Their Use and Differential Features.
Lyseng-Williamson KA
Clin Drug Investig; 2019 Oct; 39(10):1019. PubMed ID: 31512163
[TBL] [Abstract][Full Text] [Related]
32. Correction to: How the 2018 US Physical Activity Guidelines are a Call to Promote and Better Understand Acute Physical Activity for Cognitive Function Gains.
Chang YK; Erickson KI; Stamatakis E; Hung TM
Sports Med; 2020 Mar; 50(3):639. PubMed ID: 31686384
[TBL] [Abstract][Full Text] [Related]
33. Correction to: Triadic Interactions in MIECHV: Relations to Home Visit Quality.
Peterson CA; Hughes-Belding K; Rowe N; Fan L; Walter M; Dooley L; Wang W; Steffensmeier C
Matern Child Health J; 2018 Oct; 22(Suppl 1):115. PubMed ID: 30136061
[TBL] [Abstract][Full Text] [Related]
34. Correction to: Nicotine inhibits activation of microglial proton currents via interactions with α7 acetylcholine receptors.
Noda M; Kobayashi AI
J Physiol Sci; 2018 Nov; 68(6):881. PubMed ID: 29679307
[TBL] [Abstract][Full Text] [Related]
35. Publisher Correction: Inhibitory circuit gating of auditory critical-period plasticity.
Takesian AE; Bogart LJ; Lichtman JW; Hensch TK
Nat Neurosci; 2018 Oct; 21(10):1495. PubMed ID: 29915196
[TBL] [Abstract][Full Text] [Related]
36. Correction to: Meeting report of the 8
Friebe A; Sandner P; Schmidtko A
Naunyn Schmiedebergs Arch Pharmacol; 2018 Mar; 391(3):347. PubMed ID: 29362847
[TBL] [Abstract][Full Text] [Related]
37. Development of gene vectors for pinpoint targeting to human hepatocytes by cationically modified polymer complexes.
Chiba N; Ueda M; Shimada T; Jinno H; Watanabe J; Ishihara K; Kitajima M
Eur Surg Res; 2007; 39(1):23-34. PubMed ID: 17204835
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and characterisation of cationically modified phospholipid polymers.
Lewis AL; Berwick J; Davies MC; Roberts CJ; Wang JH; Small S; Dunn A; O'Byrne V; Redman RP; Jones SA
Biomaterials; 2004 Jul; 25(15):3099-108. PubMed ID: 14967544
[TBL] [Abstract][Full Text] [Related]
39. Studies on a novel multi-sensitive hydrogel: influence of the biomimetic phosphorylcholine end-groups on the PEO-PPO-PEO tri-block co-polymers.
Meng S; Guo Z; Wang Q; Liu Z; Wang Q; Zhong W; Du Q
J Biomater Sci Polym Ed; 2011; 22(4-6):651-64. PubMed ID: 20573315
[TBL] [Abstract][Full Text] [Related]
40. Correction to: Public goods and procreation.
Anomaly J
Monash Bioeth Rev; 2019 Oct; 37(1-2):79. PubMed ID: 31062293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]